Neovae Bio Medics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.10 M
as on 11-12-2024
- Company Age 6 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -35.19%
(FY 2022)
- Profit -66.97%
(FY 2022)
- Ebitda -20.26%
(FY 2022)
- Net Worth 17.15%
(FY 2022)
- Total Assets -26.47%
(FY 2022)
About Neovae Bio Medics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vinay Sharma, Abhijeet Lonkar, and Shailaja Sharma serve as directors at the Company.
- CIN/LLPIN
U74999DL2018PTC335542
- Company No.
335542
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jun 2018
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Neovae Bio Medics Private Limited offer?
Neovae Bio Medics Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Nutraceuticals & Dietary Supplements, Multivitamin Syrup & Drops, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Neovae Bio Medics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinay Sharma  | Director | 19-Jun-2018 | Current |
| Abhijeet Lonkar | Director | 19-Jun-2018 | Current |
| Shailaja Sharma | Director | 17-Nov-2018 | Current |
Financial Performance of Neovae Bio Medics.
Neovae Bio Medics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 35.19% decrease. The company also saw a substantial fall in profitability, with a 66.97% decrease in profit. The company's net worth Soared by an impressive increase of 17.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Neovae Bio Medics?
In 2021, Neovae Bio Medics had a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Neovap Bio Pharmaceutical Private LimitedActive 8 years 2 monthsVinay Sharma and Abhijeet Lonkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Neovae Bio Medics?
Unlock and access historical data on people associated with Neovae Bio Medics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Neovae Bio Medics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neovae Bio Medics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
